In fact, olaparib is blood brain barrier (BBB) penetrant and could serve as an effective brain tumor therapy (50) Considering the genomic instability of CGNPs following PARP1 and ATR ablation, there is also a potential for synergism between PARP and ATR inhibition. The gene discussed is PARP1; the disease is brain neoplasm.